160
Participants
Start Date
January 13, 2020
Primary Completion Date
December 10, 2021
Study Completion Date
February 13, 2022
Growth Hormone
In GH groups (Group 4A \& 3A), patients will receive additional treatment with GH (Somatropin, 4 IU/day, subcutaneous injection), daily beginning on the initial day of gonadotropin stimulation until triggering the oocyte maturation by hCG. Control groups (Group 4B \& 3B) will receive only standard COS without GH supplementation
faculty of medicine, Alexandria University, Alexandria
Alexandria University
OTHER